- Home
- OKYO vs NPT Comparison
OKYO vs NPT Comparison
Compare OKYO & NPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OKYO | NPT |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United Kingdom | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.2M | 64.3M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | OKYO | NPT |
|---|---|---|
| Price | $1.34 | $1.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | ★ 60.6K | 12.3K |
| Earning Date | 07-20-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.26 | $1.14 |
| 52 Week High | $3.20 | $22.38 |
Technical Indicators
Market Signals| Indicator | OKYO | NPT |
|---|---|---|
| Relative Strength Index (RSI) | 42.80 | 44.06 |
| Support Level | N/A | $1.23 |
| Resistance Level | $1.70 | $1.94 |
| Average True Range (ATR) | 0.12 | 0.16 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 40.12 | 50.00 |
Price Performance
Historical ComparisonAbout OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.
About NPT Texxon Holding Limited Ordinary shares
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.